Select Medical Holdings Co. (NYSE:SEM) Receives $39.00 Consensus PT from Analysts

Shares of Select Medical Holdings Co. (NYSE:SEMGet Free Report) have received an average rating of “Moderate Buy” from the four research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $39.00.

A number of analysts have weighed in on the company. Bank of America assumed coverage on Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price target on the stock. Benchmark restated a “buy” rating and issued a $48.00 price target on shares of Select Medical in a research note on Friday, September 6th.

Read Our Latest Research Report on SEM

Institutional Trading of Select Medical

Hedge funds and other institutional investors have recently made changes to their positions in the company. Hexagon Capital Partners LLC grew its holdings in shares of Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after buying an additional 645 shares during the last quarter. Transcendent Capital Group LLC purchased a new position in shares of Select Medical during the second quarter worth about $35,000. Canada Pension Plan Investment Board purchased a new position in shares of Select Medical during the second quarter worth about $39,000. Fidelis Capital Partners LLC purchased a new position in shares of Select Medical during the first quarter worth about $47,000. Finally, DekaBank Deutsche Girozentrale purchased a new position in shares of Select Medical during the second quarter worth about $60,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Trading Down 0.5 %

NYSE:SEM opened at $32.91 on Friday. The firm has a market cap of $4.28 billion, a PE ratio of 15.75, a price-to-earnings-growth ratio of 2.11 and a beta of 1.41. The stock has a fifty day moving average price of $34.37 and a 200 day moving average price of $33.81. Select Medical has a 12-month low of $21.28 and a 12-month high of $40.50. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 2.11.

Select Medical (NYSE:SEMGet Free Report) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). Select Medical had a net margin of 3.91% and a return on equity of 17.50%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the business earned $0.61 earnings per share. The firm’s quarterly revenue was up 5.1% on a year-over-year basis. Sell-side analysts anticipate that Select Medical will post 2.03 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date was Wednesday, August 14th. Select Medical’s dividend payout ratio (DPR) is currently 23.92%.

Select Medical Company Profile

(Get Free Report

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Articles

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.